Breathing Interventions for Relaxation: Dosing Through Extended Exhale

May 3, 2024 updated by: Alfredo Gamboa, Vanderbilt University Medical Center
Breathing exercises are categorized as a mind-body practice. One in ten adults in the U.S. use breathing exercises for health purposes. The aim of this project is to examine if different slow breathing has different physiological and psychological effects.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Breathing exercises are categorized as a mind-body practice. One in ten adults in the U.S. use breathing exercises for health purposes. Slow breathing exercises are commonly used for stress reduction. Higher stress is associated with higher cardiovascular risk. Effective and standardized breathing interventions for stress reduction have not been developed or well-studied. For centuries, mind-body practitioners have proposed that, in addition to breathing slowly, extending the length of exhale relative to inhale increases the dose of relaxation. Few studies have tested this belief. The aim of this proposal is to examine if slow breathing while extending the exhale time relative to the inhale time increases physiological and psychological relaxation. The slow breathing exercises to be studied are based on breathing techniques from yoga. This is a12-week study among healthy adults randomized to daily slow breathing exercises of: (1) exhale greater than inhale versus (2) exhale equal to inhale in length. The first aim of the studies will be to compare 12 weeks of slow breathing with exhale greater than inhale on physiological stress as measured through autonomic tone. The second aim will be to compare changes in psychological stress as measured through validated stress and anxiety questionnaires. The final and third aim will be to measure the correlation between changes in physiological and psychological stress. This project will test if specific breathing techniques produce measurable and meaningful differences in stress in both healthy and disease populations. Because stress reduction is considered the major mechanism of mind-body practices, these studies will advance the field of mind-body science.

Study Type

Interventional

Enrollment (Actual)

99

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 30 to 60 years
  • English speaking

Exclusion Criteria:

  • Hypertension
  • Heart disease: history of coronary artery disease, myocardial infarction, significant valvular disease, or congestive heart failure
  • Diabetes
  • Renal disease
  • Anxiety disorder
  • Depression
  • Other psychiatric conditions including schizophrenia or bipolar disorder
  • Attention-deficit-disorder or Attention-deficit-hyperactivity disorder
  • Musculoskeletal condition limiting capacity to perform simple movements such as chronic lower back pain or neck pain
  • Pulmonary disorder (asthma, chronic obstructive lung disease, obstructive sleep apnea)
  • Smoker
  • Currently taking blood pressure medications, oral diabetic medication or insulin
  • Current participation in a mind-body practice/program
  • Current cancer other than non- melanoma skin cancer
  • Regular swimmer
  • Plays wind or brass musical instruments

After two weeks during screening period unable to:

  • Breathe 8 or less a minute
  • Breathe 3 or less breaths a minute
  • Practiced less than 3 times a week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Slow breathing with exhale greater than inhale
Participants randomized to slow breathing with prolonged exhale to inhale ratio received progressive increases in expiration relative to inspiration based on initial assessment until they reached a goal breath length or longest comfortable breath. Prior to performing the breathing practice, subjects in this exhale>inhale condition performed the same yoga movements as the exhale-inhale group.
Slow breathing techniques from yoga
Experimental: Slow breathing with exhale equal to inhale
Participants randomized to slow breathing with equal inspiration and expiration received progressive increases in both inspiration and expiration over 4 weeks until they reach a goal breath length or longest comfortable breath. Goal breaths were assigned based on initial breath assessment. Prior to performing the breathing practice, participants performed a few standardized yoga movements. The purpose of movements was to prepare the subject to sit and focus on breathing. Subjects randomized to exhale=inhale will receive progressive increases in both inspiration and expiration until they reach a goal breath length. Goal breaths will be assigned based on initial breath assessment. Prior to performing the breathing practice, subjects will perform a set of standardized breathing practices. The purpose of these few breathing practices is to prepare the subject to sit and focus on breathing.
Slow breathing techniques from yoga

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Magnitude of Change in High Frequency Heart Rate Variability
Time Frame: Baseline
This is a proxy measure of parasympathetic tone. In normal healthy adults, the average value is around 600 ms^2 (miliseconds*miliseconds). In hypertensive adults, the average value is around 100 ms^2. In patients with autonomic failure (who lacks parasympathetic tone), the average value is around 20 ms^2.
Baseline
Magnitude of Change in High Frequency Heart Rate Variability
Time Frame: 6 weeks
This is a proxy measure of parasympathetic tone. In normal healthy adults, the average value is around 600 ms^2 (miliseconds*miliseconds). In hypertensive adults, the average value is around 100 ms^2. In patients with autonomic failure (who lacks parasympathetic tone), the average value is around 20 ms^2.
6 weeks
Magnitude of Change in High Frequency Heart Rate Variability
Time Frame: 12 weeks
This is a proxy measure of parasympathetic tone. In normal healthy adults, the average value is around 600 ms^2 (miliseconds*miliseconds). In hypertensive adults, the average value is around 100 ms^2. In patients with autonomic failure (who lacks parasympathetic tone), the average value is around 20 ms^2.
12 weeks
Magnitude of Change in PROMIS Anxiety Scale
Time Frame: Baseline

Measure of psychological stress taken at baseline before any study intervention.

The scale ranges from 0 (no anxiety) to 100 (maximal anxiety). In the normal adult population, the average of the PROMIS Cooperative Group. (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety score is 50. A higher score correlates with increased anxiety and a lower score correlates with lower anxiety.

Baseline
Magnitude of Change in PROMIS Anxiety Scale
Time Frame: 6 weeks

Measure of psychological stress taken at baseline before any study intervention.

The scale ranges from 0 (no anxiety) to 100 (maximal anxiety). In the normal adult population, the average of the PROMIS Cooperative Group. (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety score is 50. A higher score correlates with increased anxiety and a lower score correlates with lower anxiety.

6 weeks
Magnitude of Change in PROMIS Anxiety Scale
Time Frame: 12-weeks

Measure of psychological stress taken at baseline before any study intervention.

The scale ranges from 0 (no anxiety) to 100 (maximal anxiety). In the normal adult population, the average of the PROMIS Cooperative Group. (2011). Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety score is 50. A higher score correlates with increased anxiety and a lower score correlates with lower anxiety.

12-weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Magnitude of change in baroreflex sensitivity
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of parasympathetic tone
Baseline, 6 weeks, and 12 weeks
Magnitude of change in PROMIS Depression scale
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of negative affect
Baseline, 6 weeks, and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Magnitude of change in Perceived Stress Scale
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of changes in stress
Baseline, 6 weeks, and 12 weeks
Magnitude of change in Anxiety Sensitivity Index-3
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of changes in stress
Baseline, 6 weeks, and 12 weeks
Magnitude of change in Beck Anxiety Inventory
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of changes in stress
Baseline, 6 weeks, and 12 weeks
Magnitude of change in Body Vigilance Scale
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of changes in stress
Baseline, 6 weeks, and 12 weeks
Magnitude of change in Panic Disorder Severity Scale
Time Frame: Baseline, 6 weeks, and 12 weeks
Measure of changes in stress
Baseline, 6 weeks, and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gurjeet Birdee, MD, Vanderbilt University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2016

Primary Completion (Actual)

December 19, 2018

Study Completion (Actual)

December 19, 2018

Study Registration Dates

First Submitted

August 12, 2016

First Submitted That Met QC Criteria

August 12, 2016

First Posted (Estimated)

August 17, 2016

Study Record Updates

Last Update Posted (Actual)

May 29, 2024

Last Update Submitted That Met QC Criteria

May 3, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 160817
  • 1R61AT009340 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Slow breathing

Subscribe